These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3521187)

  • 1. Advanced stage III ovarian carcinoma. Prospective randomized trials comparing radiotherapy and chemotherapy.
    Sigurdsson K
    Acta Obstet Gynecol Scand; 1986; 65(1):69-74. PubMed ID: 3521187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-intensive induction therapy with cyclophosphamide, cisplatin, and consolidative abdominal radiation in advanced-stage epithelial ovarian cancer.
    Rothenberg ML; Ozols RF; Glatstein E; Steinberg SM; Reed E; Young RC
    J Clin Oncol; 1992 May; 10(5):727-34. PubMed ID: 1569445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of high dose abdominopelvic radiotherapy following surgery and chemotherapy for stage III epithelial carcinoma of the ovary.
    Coltart RS; Nethersell AB; Brown CH
    Gynecol Oncol; 1986 Jan; 23(1):105-10. PubMed ID: 3510945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma of the ovary in stage III. Effects of postoperative chemotherapy, radiation therapy and repeat laparotomy.
    Sigurdsson K; Johnsson JE; Tropé C
    Acta Radiol Oncol; 1982; 21(3):181-9. PubMed ID: 6293259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized, national trial for treatment of ovarian cancer: the role of chemotherapy and external irradiation.
    Grönroos M; Nieminen U; Kauppila A; Kauppila O; Saksela E; Väyrynen M
    Eur J Obstet Gynecol Reprod Biol; 1984 Apr; 17(1):33-42. PubMed ID: 6376194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomized trial comparing high-dose cisplatin with low-dose cisplatin and chlorambucil in advanced ovarian carcinoma.
    Wiltshaw E; Evans B; Rustin G; Gilbey E; Baker J; Barker G
    J Clin Oncol; 1986 May; 4(5):722-9. PubMed ID: 3517243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of early epithelial ovarian cancer with chemotherapy and abdominopelvic radiotherapy: results of a prospective treatment protocol.
    Wong R; Milosevic M; Sturgeon J; Pintilie M; Fyles A; Levin W; Rosen B; Depetrillo D; Oza A; Manchul L; Murphy J; Chapman W
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):657-65. PubMed ID: 10524420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial comparing single-agent carboplatin with carboplatin followed by radiotherapy for advanced ovarian cancer: a North Thames Ovary Group study.
    Lambert HE; Rustin GJ; Gregory WM; Nelstrop AE
    J Clin Oncol; 1993 Mar; 11(3):440-8. PubMed ID: 8445418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy and radiation therapy in the treatment of ovarian carcinoma of common epithelial origin.
    Wharton JT; Edwards CL; Stringer CA; Delclos L
    Clin Obstet Gynecol; 1985 Dec; 28(4):806-15. PubMed ID: 4075632
    [No Abstract]   [Full Text] [Related]  

  • 11. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.
    Trimbos JB; Parmar M; Vergote I; Guthrie D; Bolis G; Colombo N; Vermorken JB; Torri V; Mangioni C; Pecorelli S; Lissoni A; Swart AM; ;
    J Natl Cancer Inst; 2003 Jan; 95(2):105-12. PubMed ID: 12529343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. A prospective double blind randomized trial. Decapeptyl Ovarian Cancer Study Group.
    Emons G; Ortmann O; Teichert HM; Fassl H; Löhrs U; Kullander S; Kauppila A; Ayalon D; Schally A; Oberheuser F
    Cancer; 1996 Oct; 78(7):1452-60. PubMed ID: 8839551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: a randomized, controlled, clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatment.
    Sorbe B;
    Int J Gynecol Cancer; 2003; 13(3):278-86. PubMed ID: 12801256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytoprotective effect of Amifostine in the combined chemotherapy of advanced ovarian carcinoma].
    Nagy P; Kádasi L
    Orv Hetil; 2000 Sep; 141(37):2027-30. PubMed ID: 11037611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
    Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA
    Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
    J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of the 1st Austrian ovarian cancer study: prospective randomized comparison of a new sequential chemotherapy with 2 standard regimens in 150 stage III and IV patients].
    Sevelda P; Salzer H; Gitsch E; Karrer K
    Onkologie; 1985 Dec; 8(6):388-91. PubMed ID: 3912695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of the first Austrian multicenter ovarian cancer study: prospective randomized comparison of sequential chemotherapy (adriamycin/cisplatin--vincristine/cyclophosphamide--methotrexate) with 2 standard protocols (adriamycin/cyclophosphamide or adriamycin/cisplatin) in stage III and IV patients].
    Salzer H; Gitsch E; Dittrich C; Sevelda P; Karrer K; Schemper M; Stempel-Smekal G; Langer M; Wagner G; Rainer H
    Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):761-8. PubMed ID: 3908214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgery in the treatment concept of epithelial ovarian cancer].
    Salzer H; Genger H; Gober S; Barrada M; Vavra N; Sevelda P
    Gynakol Rundsch; 1990; 30 Suppl 1():26-9. PubMed ID: 2079293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.